Rosemary*

Age

  • 78 years old


History of present illness

  • Alzheimer's disease initially diagnosed/first symptoms ~8 years prior to clinical screening
  • APOE4(-)


Medical history

  • Hypercholesterolemia
  • Hypertension
  • Arthritis
  • Orthostatic dizziness
  • Sleep difficulty


Concomitant medications

  • Simvastatin for hypercholesterolemia
  • Glucosamine with chondroitin sulfates for arthritis
  • Flaxseed and cod liver oil supplements


Clinical exam

  • Baseline Alzheimer’s Disease Assessment Scale–Cognitive subscale (ADAS–Cog) of 31
  • Baseline Mini-Mental State Exam (MMSE) of 15


Management

  • Axona 40 g QD added to existing treatment
Measurement of ADAS–Cog and MMSE
Study visit
ADAS–Coga Change in ADAS–Coga MMSEb
Screening
27 N/A
16
Baseline
31 N/A 15
Day 45
23 -8
15
Day 90
20 -11
17
Day 104
(after 14 days of no treatment, per study protocol)
21 -10
16
aLower scores indicate improvement.
bHigher scores indicate improvement.


Follow-up

  • ADAS–Cog score progressively improved at days 45 and 90
  • ADAS–Cog score remained improved at the washout visit (day 104)

*Based on a real patient. Name has been changed.